431 related articles for article (PubMed ID: 17090777)
1. The clinical and immunological features of leprosy.
Walker SL; Lockwood DN
Br Med Bull; 2006; 77-78():103-21. PubMed ID: 17090777
[TBL] [Abstract][Full Text] [Related]
2. Leprosy.
Walker SL; Lockwood DN
Clin Dermatol; 2007; 25(2):165-72. PubMed ID: 17350495
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the treatment of leprosy.
Ishii N
Dermatol Online J; 2003 Mar; 9(2):5. PubMed ID: 12639458
[TBL] [Abstract][Full Text] [Related]
4. [Hansen's disease: case report and review of literature].
Concha R M; Cossio T ML; Salazar S I; Fich S F; Pérez C C; González B S
Rev Chilena Infectol; 2008 Feb; 25(1):64-9. PubMed ID: 18273528
[TBL] [Abstract][Full Text] [Related]
5. Neurological manifestations of Hansen's disease and their management.
Agrawal A; Pandit L; Dalal M; Shetty JP
Clin Neurol Neurosurg; 2005 Oct; 107(6):445-54. PubMed ID: 16202816
[TBL] [Abstract][Full Text] [Related]
6. Leprosy.
Sehgal VN
Dermatol Clin; 1994 Oct; 12(4):629-44. PubMed ID: 7805293
[TBL] [Abstract][Full Text] [Related]
7. Disabilities in multibacillary leprosy following multidrug therapy with and without immunotherapy with Mycobacterium w antileprosy vaccine.
Sharma P; Kar HK; Misra RS; Mukherjee A; Kaur H; Mukherjee R; Rani R
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):250-8. PubMed ID: 10575404
[TBL] [Abstract][Full Text] [Related]
8. Treatment of leprosy/Hansen's disease in the early 21st century.
Worobec SM
Dermatol Ther; 2009; 22(6):518-37. PubMed ID: 19889136
[TBL] [Abstract][Full Text] [Related]
9. Features of relapse in paucibacillary leprosy after multidrug therapy.
Naafs B
Indian J Lepr; 1995; 67(1):61-7. PubMed ID: 7622931
[No Abstract] [Full Text] [Related]
10. [Eradication of leprosy and public health. Vaccination and multidrug therapy].
Janaszek W
Przegl Epidemiol; 2002; 56(4):577-86. PubMed ID: 12666583
[TBL] [Abstract][Full Text] [Related]
11. [Leprosy, a neurologic disease].
Coeytaux A; Truffert A; Mueller Y; Antille C; Jackson Y
Rev Med Suisse; 2007 May; 3(110):1178, 1180-4. PubMed ID: 17564345
[TBL] [Abstract][Full Text] [Related]
12. Incidence of nerve damage in leprosy patients treated with MDT.
Solomon S; Kurian N; Ramadas P; Rao PS
Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):451-6. PubMed ID: 10347565
[TBL] [Abstract][Full Text] [Related]
13. Leprosy now: epidemiology, progress, challenges, and research gaps.
Rodrigues LC; Lockwood DNj
Lancet Infect Dis; 2011 Jun; 11(6):464-70. PubMed ID: 21616456
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and treatment of leprosy].
López-Antuñano FJ
Salud Publica Mex; 1998; 40(1):66-75. PubMed ID: 9580503
[No Abstract] [Full Text] [Related]
15. Leprous neuropathies.
Waters MF; Jacobs JM
Baillieres Clin Neurol; 1996 Mar; 5(1):171-97. PubMed ID: 8732207
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of leprosy.
Krishnamurthy P
J Indian Med Assoc; 2006 Dec; 104(12):680-1, 685. PubMed ID: 17474284
[TBL] [Abstract][Full Text] [Related]
17. WHO Expert Committee on Leprosy.
World Health Organ Tech Rep Ser; 1998; 874():1-43. PubMed ID: 9627517
[TBL] [Abstract][Full Text] [Related]
18. [Neurological manifestations of leprosy].
Grimaud J; Vallat JM
Rev Neurol (Paris); 2003 Nov; 159(11):979-95. PubMed ID: 14710019
[TBL] [Abstract][Full Text] [Related]
19. Comment: Persistence of Mycobacterium leprae in the peripheral nerves of multidrug-treated leprosy patients.
Grange JM; Beck JS; Abbot NC
Lepr Rev; 1993 Sep; 64(3):280. PubMed ID: 8110236
[No Abstract] [Full Text] [Related]
20. [Leprosy. Classification--clinical aspects--diagnosis--therapy].
Stingl P
Z Hautkr; 1982 Nov; 57(21):1559-67. PubMed ID: 7148071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
